Cyteir Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cyteir Therapeutics generated cash of -$42,532,000, which is less than the previous year. Cash used in financing activities reached the amount of $242,000 last year. Net change in cash is therefore -$42,602,000.
Cash Flow
| 2019 | -17.55M | -133K | 36.89M |
|---|---|---|---|
| 2020 | -18.53M | -850K | 1.42M |
| 2021 | -36.03M | -1.18M | 216.00K |
| 2022 | -42.53M | -312K | 242K |
CYT Cash Flow Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 189.97M | 11.19M | 29.15M | 9.95M |
Operating activities | ||||
Net income | -46.06M | -42.12M | -20.82M | -15.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 668K | 479K | 351K | 215K |
Stock-based compensation expense | 4.68M | 3.46M | 467K | 247K |
| Deferred income tax benefit | 4.68M | 3.46M | 467K | 247K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | -657K | 38K | 1.02M | -884K |
Cash generated by operating activities | -42.53M | -36.03M | -18.53M | -17.55M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -312K | -1.18M | -850K | -133K |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -312K | -1.18M | -850K | -133K |
Financing activities | ||||
Common Stock Issued | 64K | 0 | 1.42M | 36.89M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 |
Cash used in financing activities | 242K | 216.00K | 1.42M | 36.89M |
Net Change In Cash | -42.60M | 178.78M | -17.96M | 19.2M |
Cash at end of period | 147.37M | 189.97M | 11.19M | 29.15M |
| Data source | Data source |